311 related articles for article (PubMed ID: 10930495)
21. Management of mycoses in surgical patients -- review of the literature.
Holzheimer RG; Dralle H
Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of fungal infections in liver transplant recipients: a six-year study of a large Brazilian liver transplantation centre.
Zicker M; Colombo AL; Ferraz-Neto BH; Camargo LF
Mem Inst Oswaldo Cruz; 2011 May; 106(3):339-45. PubMed ID: 21655823
[TBL] [Abstract][Full Text] [Related]
23. The risk factors of fungal infection in living-donor liver transplantations.
Ohkubo T; Sugawara Y; Takayama T; Kokudo N; Makuuchi M
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):382-8. PubMed ID: 21792556
[TBL] [Abstract][Full Text] [Related]
24. Outcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients.
Saliba F; Delvart V; Ichaï P; Kassis N; Botterel F; Mihaila L; Azoulay D; Adam R; Castaing D; Bretagne S; Samuel D
Med Mycol; 2013 Feb; 51(2):155-63. PubMed ID: 22800082
[TBL] [Abstract][Full Text] [Related]
25. Candida infection in pediatric liver transplant recipients.
Gladdy RA; Richardson SE; Davies HD; Superina RA
Liver Transpl Surg; 1999 Jan; 5(1):16-24. PubMed ID: 9873087
[TBL] [Abstract][Full Text] [Related]
26. DCD liver transplant infection: experience from a single centre in China.
Tu Z; Xiang P; Xu X; Zhou L; Zhuang L; Wu J; Wang W; Zheng S
Int J Clin Pract; 2016 Jun; 70 Suppl 185():3-10. PubMed ID: 27197998
[TBL] [Abstract][Full Text] [Related]
27. Invasive fungal infections in renal transplant recipients: about 11 cases.
Trabelsi H; Néji S; Sellami H; Yaich S; Cheikhrouhou F; Guidara R; Charffedine K; Makni F; Hachicha J; Ayadi A
J Mycol Med; 2013 Dec; 23(4):255-60. PubMed ID: 24060353
[TBL] [Abstract][Full Text] [Related]
28. Viral and fungal infections after liver transplantation--part II.
Kusne S; Blair JE
Liver Transpl; 2006 Jan; 12(1):2-11. PubMed ID: 16382451
[TBL] [Abstract][Full Text] [Related]
29. Antifungal prophylaxis in solid organ transplant recipients.
Brizendine KD; Vishin S; Baddley JW
Expert Rev Anti Infect Ther; 2011 May; 9(5):571-81. PubMed ID: 21609268
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and outcome of fungal infection in patients with severe acute pancreatitis.
Kochhar R; Ahammed SK; Chakrabarti A; Ray P; Sinha SK; Dutta U; Wig JD; Singh K
J Gastroenterol Hepatol; 2009 May; 24(5):743-7. PubMed ID: 19220667
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and treatment of fungal infection after liver transplantation.
Shi XJ; Lü SC; He L; Lu F; Liang YR; Luo Y; Ji WB; Zhao ZM
Chin Med J (Engl); 2011 Apr; 124(7):1015-7. PubMed ID: 21542960
[TBL] [Abstract][Full Text] [Related]
32. Micafungin versus amphotericin B lipid complex for the prevention of invasive fungal infections in high-risk liver transplant recipients.
Sun HY; Cacciarelli TV; Singh N
Transplantation; 2013 Sep; 96(6):573-8. PubMed ID: 23842191
[TBL] [Abstract][Full Text] [Related]
33. Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients.
Bodro M; Sabé N; Gomila A; Ayats J; Baliellas C; Roca J; Melilli E; Carratalà J
Transplant Proc; 2012 Nov; 44(9):2682-5. PubMed ID: 23146493
[TBL] [Abstract][Full Text] [Related]
34. [Postoperative intensive care of biliary atresia patients treated with living donor liver transplantation].
Deng YH; Guo CB; Zhang MM; Li YC
Zhonghua Er Ke Za Zhi; 2011 Jan; 49(1):21-6. PubMed ID: 21429307
[TBL] [Abstract][Full Text] [Related]
35. [Nosocomial fungal infections, analysis of 149 cases].
Liu ZY; Sheng RY; Li XL; Li TS; Wang AX
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):399-402. PubMed ID: 12820917
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
[TBL] [Abstract][Full Text] [Related]
37. Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection.
Tissot F; Pascual M; Hullin R; Yerly P; Tozzi P; Meylan P; Manuel O
Transplantation; 2014 Jun; 97(11):1192-7. PubMed ID: 24521774
[TBL] [Abstract][Full Text] [Related]
38. Fungal infections after liver transplantation: incidence and outcome.
Sganga G; Bianco G; Frongillo F; Lirosi MC; Nure E; Agnes S
Transplant Proc; 2014 Sep; 46(7):2314-8. PubMed ID: 25242777
[TBL] [Abstract][Full Text] [Related]
39. Fungal complications after Candida preservation fluid contamination in liver transplant recipients.
Levesque E; Paugam-Burtz C; Saliba F; Khoy-Ear L; Merle JC; Jung B; Stecken L; Ferrandiere M; Mihaila L; Botterel F
Transpl Int; 2015 Nov; 28(11):1308-16. PubMed ID: 26147662
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis.
Chong PP; Kennedy CC; Hathcock MA; Kremers WK; Razonable RR
Clin Transplant; 2015 Apr; 29(4):311-8. PubMed ID: 25604399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
